Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Neuroscience

• Publication date

  1997-03-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0306-4522(96)00569-6PMID 9153647
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease

  2004cited by this paper
• Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Nucleus basalis Meynert neurons contain the vitamin D-induced calcium-binding protein (Calbindin-D 28k)

  2004cited by this paper
• Senile plaques, amyloid β-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex

  2004cited by this paper
• Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease.

  1996cited by this paper
• Reproducible sampling regimen for specific cortical regions: application to speech-associated areas.

  1996cited by this paper
• Topography of brain atrophy during normal aging and Alzheimer's disease.

  1996cited by this paper
• Improved selectivity and sensitivity in the visualization of neurofibrillary tangles, plaques and neuropil threads.

  1996cited by this paper
• Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions

  1995cited by this paper
• Cholinergic basal forebrain neurons project to cortical microvessels in the rat: electron microscopic study with anterogradely transported Phaseolus vulgaris leucoagglutinin and choline acetyltransferase immunocytochemistry

  1995cited by this paper
• The CERAD experience, part VIII

  1995cited by this paper
• MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report.

  1995cited by this paper
• Differential degeneration of the cerebral microvasculature in Alzheimer's disease.

  1995cited by this paper
• Long-term effects of tacrine on regional cerebral blood flow changes in Alzheimer's disease.

  1995cited by this paper
• The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update.

  1995cited by this paper
• Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease.

  1995cited by this paper
• Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders

  1994cited by this paper
• Analysis of staining methods for different cortical plaques in Alzheimer's disease

  1994cited by this paper
• No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type.

  1994cited by this paper
• Are you using neuronal densities, synaptic densities or neurochemical densities as your definitive data? There is a better way to go.

  1994cited by this paper
• Basal forebrain control of cortical cerebral blood flow is independent of local cortical neurons.

  1993cited by this paper
• Hippocampal atrophy in normal aging. An association with recent memory impairment.

  1993cited by this paper
• Quantitation and three‐dimensional reconstruction of Ch4 nucleus in the human basal forebrain

  1993cited by this paper
• Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease

  1993cited by this paper
• A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

  1992cited by this paper
• Are there sequential morphometrical changes in the nucleus basalis in Alzheimer's disease?

  1992cited by this paper
• A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease.

  1992cited by this paper
• MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease

  1992cited by this paper
• Alzheimer's disease: Is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?

  1992cited by this paper
• A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

  1992cited by this paper
• Very mild Alzheimer's disease

  1991cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Morphometric study on the CH4 of the nucleus basalis of Meynert in Alzheimer's disease.

  1991cited by this paper
• Cell loss and nuclear hypertrophy in topographical subdivisions of the nucleus basalis of Meynert in Alzheimer's disease.

  1991cited by this paper
• Rapid, Reliable and Economical Silver Stain for Neurofibrillary Tangles and Senile Plaques

  1991cited by this paper
• Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease.

  1990cited by this paper
• Human brain cholinergic pathways.

  1990cited by this paper
• A case‐control study of Alzheimer's disease in Australia

  1990cited by this paper
• Chapter 26 Human brain cholinergic pathways

  1990cited by this paper
• Thalamic nuclei in Alzheimer disease: evidence against the cholinergic hypothesis of plaque formation.

  1989cited by this paper
• Some new, simple and efficient stereological methods and their use in pathological research and diagnosis

  1988cited by this paper
• Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase

  1988cited by this paper
• Astrocyte Diversity

  1988cited by this paper
• Fiber pathways of basal forebrain cholinergic neurons in monkeys.

  1987cited by this paper
• Early‐onset Alzheimer's disease

  1987cited by this paper
• Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain.

  1986cited by this paper
• Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease.

  1985cited by this paper
• Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey

  1983cited by this paper
• Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

  1981cited by this paper
• über eigenartige Krankheitsfälle des späteren Alters

  1911cited by this paper

• Cholinergic basal forebrain atrophy and cortical alterations in Parkinson's disease with apathy.

  2025cites this paper
• Independent and additive contribution of white matter hyperintensities and Alzheimer’s disease pathology to basal forebrain cholinergic system degeneration

  2023cites this paper
• Basal Forebrain Atrophy, Cortical Thinning, and Amyloid‐β Status in Parkinson's disease‐Related Cognitive Decline

  2023cites this paper
• Amidated Dopamine Neuron Stimulating Peptides for CNS Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation Dopaminergic Upregulation

  2022cites this paper
• Mild Traumatic Brain Injury Results in Significant and Lasting Cortical Demyelination

  2022cites this paper
• Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology.

  2021cites this paper
• Use of 192 IgG-saporin as a model of dementia and its application

  2020cites this paper
• The neuritic plaque in Alzheimer's disease: perivascular degeneration of neuronal processes.

  2019cites this paper
• Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease.

  2019cites this paper
• Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation

  2017cites this paper
• Altered Functional Connectivity of the Basal Nucleus of Meynert in Mild Cognitive Impairment: A Resting-State fMRI Study

  2017cites this paper
• MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease.

  2016cites this paper
• Volume Loss of the Nucleus Basalis of Meynert is Associated with Atrophy of Innervated Regions in Mild Cognitive Impairment

  2016cites this paper
• Inhibition of Histone Deacetylase 3 Restores Amyloid-β Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons

  2016cites this paper
• Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease.

  2016cites this paper
• Expediting the Discovery and Potential Translation of Theranostic Agents for Alzheimer's Disease

  2015cites this paper
• The Brain Cholinergic System in Neurodegenerative Diseases

  2015cites this paper
• S 100 b Counteracts Neurodegeneration of Rat Cholinergic Neurons in Brain Slices after Oxygen-Glucose Deprivation

  2014cites this paper
• Functional and Structural MRI in Alzheimer’s Disease: A Multimodal Approach

  2014cites this paper
• DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease

  2014cites this paper
• Amyloid Beta Peptides Differentially Affect Hippocampal Theta Rhythms In Vitro

  2013cites this paper
• Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia.

  2012cites this paper
• Preservation of neurons of the nucleus basalis in subcortical ischemic vascular disease.

  2012cites this paper
• The 5XFAD mouse model: a tool for genetic modulation of Alzheime's disease pathology

  2012cites this paper
• Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy

  2012cites this paper
• Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease.

  2010cites this paper
• S100b Counteracts Neurodegeneration of Rat Cholinergic Neurons in Brain Slices after Oxygen-Glucose Deprivation

  2010cites this paper
• Quantifizierung regionaler Atrophie der grauen Substanz und des Corpus callosum bei Patienten mit Alzheimer Erkrankung und vaskulärer Demenz im Vergleich zu gesunden älteren Kontrollpersonen

  2009cites this paper
• Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies

  2009cites this paper
• The septo-hippocampal system, learning and recovery of function.

  2009cites this paper
• Computer-assisted 3D reconstruction of the human basal forebrain complex

  2007cites this paper
• Cytoskeletal Transport in the Aging Brain: Focus on the Cholinergic System

  2006cites this paper
• Aus der Klinik und Poliklinik für Psychiatrie und Psychotherapie des Universitätsklinikums Hamburg-Eppendorf

  2006cites this paper
• Cognitive Enhancing Properties and Tolerability of Cholinergic Agents in Mice: A Comparative Study of Nicotine, Donepezil, and SIB-1553A, a Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors

  2003cites this paper
• Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis.

  2003cites this paper
• Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders.

  2003cites this paper
• Modulation of cholinergic transmission enhances excitability of hippocampal pyramidal neurons and ameliorates learning impairments in aging animals.

  2003cites this paper
• Neocortical Glial Cell Numbers in Alzheimer’s Disease

  2003cites this paper
• The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system.

  2002cites this paper
• Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.

  2002cites this paper
• Brain aging and Alzheimer's disease; use it or lose it.

  2002cites this paper
• Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.

  2001cites this paper
• Alzheimer's disease: its diagnosis and pathogenesis.

  2001cites this paper
• Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence.

  2001cites this paper
• Brain Aging in Strepsirhine Primates

  2001cites this paper
• Long-term evolution of local, proximal and remote astrocyte responses after diverse nucleus basalis lesioning (an experimental Alzheimer model): GFAP immunocytochemical study.

  2000cites this paper
• Nerve Growth Factor Treatment for Alzheimer’s Disease: The Experience of the First Attempt at Intracerebral Neurotrophic Factor Therapy

  1999cites this paper
• Severe neuronal losses with age in the parietal cortex and ventrobasal thalamus of mice transgenic for the human NF‐L neurofilament protein

  1999cites this paper
• Enhanced learning by posttrial injection of H1-but not H2-histaminergic antagonists into the nucleus basalis magnocellularis region.

  1999cites this paper
• Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease.

  1999cites this paper
• Neurotransmitters, peptides, and neural cell adhesion molecules in the cortices of normal elderly humans and Alzheimer patients: a comparison.

  1999cites this paper
• Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia

  1999influential citation
• Neurons and mechanisms of neuronal death in neurodegenerative diseases: a brief review.

  1999cites this paper
• Magnetic resonance microscopy of iron in the basal forebrain cholinergic structures of the aged mouse lemur.

  1999cites this paper
• Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain.

  1999cites this paper
• Neonatal treatment with 192 IgG-saporin produces long-term forebrain cholinergic deficits and reduces dendritic branching and spine density of neocortical pyramidal neurons.

  1998influential citation
• Variation in hippocampal neuron number with age and brain volume.

  1998cites this paper
• A structural basis for memory storage in mammals.

  1998cites this paper
• Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease

  1998cites this paper
• Distinctive Morphological Features of a Subset of Cortical Neurons Grown in the Presence of Basal Forebrain Neurons In Vitro

  1998cites this paper
• Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology.

  1998cites this paper
• Non‐mnestic cognitive function in the scopolamine model of Alzheimer's Disease

  1998cites this paper
• The nucleus basalis (Ch4) in the alcoholic Wernicke-Korsakoff syndrome: reduced cell number in both amnesic and non-amnesic patients

  1997cites this paper